z-logo
open-access-imgOpen Access
Genetic variations in LIGHT are associated with susceptibility to ankylosing spondylitis in a Chinese Han population
Author(s) -
Bin Yang,
Junlong Zhang,
Lixin Li,
Xiaojun Lyu,
Wei Wei,
Zhuochun Huang,
Bei Cai,
Lanlan Wang
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.20644
Subject(s) - ankylosing spondylitis , single nucleotide polymorphism , genetic predisposition , pathogenesis , immunology , btla , allele , medicine , population , genetics , biology , genotype , gene , t lymphocyte , immune system , environmental health
Ankylosing spondylitis (AS) is a common chronic autoimmune disease characterized by inflammation of axial skeleton and has strong genetic susceptibility. Single nucleotide polymorphisms (SNPs) have been found playing an important role in the development of AS. This study intends to explore whether the susceptibility to AS is associated with rs2171513 C>T, rs1077667 G>A in LIGHT (lymphotoxin, expressed on T lymphocytes) and rs12609318 A>G in B and T lymphocyte attenuator (BTLA) in a Chinese Han population. We studied a total of 497 AS patients and 387 healthy controls in the current research. Clinical characteristics were recorded when they were recruited. Single nucleotide polymorphisms (SNPs) were genotyped by polymerase chain reaction (PCR) and high-resolution melting methods (HRM). Statistically significant difference was found in both co-dominant model (GG vs. GA vs. AA) (p = 4.00E-06) and alleles (p = 4.59E-08) of rs1077667 between patients and controls. There was also a significant difference in alleles of rs2171513 (p = 0.037) between patients and controls. We found rs1077667 in LIGHT and rs2171513 in BTLA with susceptibility to AS, while 12609318 in LIGHT associate with susceptibility to AS. Our results showed that LIGHT might be involved in pathogenesis of AS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here